0001192482-19-000443.txt : 20191122
0001192482-19-000443.hdr.sgml : 20191122
20191122170345
ACCESSION NUMBER: 0001192482-19-000443
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191121
FILED AS OF DATE: 20191122
DATE AS OF CHANGE: 20191122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Recro Pharma, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39101
FILM NUMBER: 191242418
BUSINESS ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (484) 395-2400
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Baudax Bio, Inc.
CENTRAL INDEX KEY: 0001780097
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 474639500
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 484-395-2470
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER COMPANY:
FORMER CONFORMED NAME: Recro Enterprises, Inc.
DATE OF NAME CHANGE: 20190618
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-11-21
1
0001780097
Baudax Bio, Inc.
BXRX
0001588972
Recro Pharma, Inc.
490 LAPP ROAD
MALVERN,
PA
19355
0
0
1
0
Common Stock
2019-11-21
4
J
0
9211145
0
A
9211245
D
Common Stock
2019-11-21
4
J
0
9211245
0
D
0
D
On November 21, 2019, Baudax Bio, Inc. ("Baudax") issed 9,211,145 shares of its common stock to its parent, Recro Pharma, Inc. ("Recro").
On November 21, 2019, Recro made a pro rata distribution of 100% of the outstanding shares of Baudax common stock to Recro stockholders of record as of November 15, 2019, the record date for the distribution.
Ryan D. Lake, Chief Financial Officer on behalf of Recro Pharma, Inc.
2019-11-22